{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T01:19:46Z","timestamp":1789003186284,"version":"build-2803163510"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T00:00:00Z","timestamp":1655683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T00:00:00Z","timestamp":1655683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Neuropsychiatric side effects of cardiac drugs such as nervousness, mood swings and agitation may be misinterpreted as symptoms of anxiety. Anxiety in cardiac patients is highly prevalent and associated with poor outcomes, thus an accurate identification is essential. The objectives were to: (I) describe the possible neuropsychiatric side effects of common cardiac drug therapies, (II) describe the use of cardiac drug therapy in cardiac patients with self-reported symptoms of anxiety compared to those with no symptoms of anxiety, and (III) investigate the association between the use of cardiac drug therapy and self-reported symptoms of anxiety.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>DenHeart is a large national cross-sectional survey combined with national register data. Symptoms of anxiety were measured by the Hospital Anxiety and Depression Scale (HADS-A) on patients with ischemic heart disease, arrhythmia, heart failure and heart valve disease. Side effects were obtained from \u2018product summaries\u2019, and data on redeemed prescriptions obtained from the Danish National Prescription Registry. Multivariate logistic regression analyses explored the association between cardiac drug therapies and symptoms of anxiety (HADS-A\u2009\u2265\u20098).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 8998 respondents 2891 (32%) reported symptoms of anxiety (HADS-A\u2009\u2265\u20098). Neuropsychiatric side effects were reported from digoxin, antiarrhythmics, beta-blockers, ACE-inhibitors and angiotensin receptor antagonists. Statistically significant higher odds of reporting HADS\u2009\u2265\u20098 was found in users of diuretics, lipid-lowering agents, nitrates, antiarrhythmics and beta-blockers compared to patients with no prescription.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Some cardiac drugs were associated with self-reported symptoms of anxiety among patients with cardiac disease. Of these drugs neuropsychiatric side effects were only reported for antiarrhythmics and beta-blockers. Increased awareness about the possible adverse effects from these drugs are important.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12872-022-02724-4","type":"journal-article","created":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T15:02:41Z","timestamp":1655737361000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The association between cardiac drug therapy and anxiety among cardiac patients: results from the national DenHeart survey"],"prefix":"10.1186","volume":"22","author":[{"given":"Camilla","family":"Rotvig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Vinggaard","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Knud","family":"Juel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper Hastrup","family":"Svendsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin Balslev","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trine Bernholdt","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britt","family":"Borregaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Thrysoee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte Brun","family":"Thorup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rikke Elmose","family":"Mols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selina Kikkenborg","family":"Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,20]]},"reference":[{"issue":"13","key":"2724_CR1","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1177\/2047487317711334","volume":"24","author":"N Pogosova","year":"2017","unstructured":"Pogosova N, Kotseva K, De Bacquer D, von K\u00e4nel R, De Smedt D, Bruthans J, Dolzhenko M. Psychosocial risk factors in relation to other cardiovascular risk factors in coronary heart disease: results from the EUROASPIRE IV survey. A registry from the European society of cardiology. Euro J Prev Cardiol. 2017;24(13):1371\u201380. https:\/\/doi.org\/10.1177\/2047487317711334.","journal-title":"Euro J Prev Cardiol"},{"key":"2724_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jpsychores.2017.01.003","volume":"94","author":"SK Berg","year":"2017","unstructured":"Berg SK, Rasmussen TB, Thrysoee L, Lauberg A, Borregaard B, Christensen AV, et al. DenHeart: differences in physical and mental health across cardiac diagnoses at hospital discharge. J Psychosom Res. 2017;94:1\u20139.","journal-title":"J Psychosom Res"},{"issue":"6","key":"2724_CR3","first-page":"651","volume":"16","author":"TA Hanssen","year":"2009","unstructured":"Hanssen TA, Nordrehaug JE, Eide GE, Bjelland I, Rokne B. Anxiety and depression after acute myocardial infarction: an 18-month follow-up study with repeated measures and comparison with a reference population. Eur J Cardiovasc Prev Rehabil Off J Eur Soc Cardiol Work Groups Epidemiol Prev Card Rehabil Exerc Physiol. 2009;16(6):651\u20139.","journal-title":"Eur J Cardiovasc Prev Rehabil Off J Eur Soc Cardiol Work Groups Epidemiol Prev Card Rehabil Exerc Physiol"},{"issue":"6","key":"2724_CR4","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.ahj.2015.09.013","volume":"170","author":"CM Celano","year":"2015","unstructured":"Celano CM, Millstein RA, Bedoya CA, Healy BC, Roest AM, Huffman JC. Association between anxiety and mortality in patients with coronary artery disease: a meta-analysis. Am Heart J. 2015;170(6):1105\u201315. https:\/\/doi.org\/10.1016\/j.ahj.2015.09.013.","journal-title":"Am Heart J"},{"issue":"6","key":"2724_CR5","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361\u201370. https:\/\/doi.org\/10.1111\/j.1600-0447.1983.tb09716.x.","journal-title":"Acta Psychiatr Scand"},{"key":"2724_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-016-0739-5","author":"CM Celano","year":"2016","unstructured":"Celano CM, Daunis DJ, Lokko HN, Campbell KA, Huffman JC. Anxiety disorders and cardiovascular disease. Curr Psychiatry Rep. 2016. https:\/\/doi.org\/10.1007\/s11920-016-0739-5.","journal-title":"Curr Psychiatry Rep"},{"issue":"4","key":"2724_CR7","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.jpsychores.2010.04.006","volume":"69","author":"C Brennan","year":"2010","unstructured":"Brennan C, Worrall-Davies A, McMillan D, Gilbody S, House A. The hospital anxiety and depression scale: a diagnostic meta-analysis of case-finding ability. J Psychosom Res. 2010;69(4):371\u20138.","journal-title":"J Psychosom Res"},{"key":"2724_CR8","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jpsychores.2019.03.183","volume":"121","author":"SK Berg","year":"2019","unstructured":"Berg SK, Herning M, Thygesen LC, Cromhout PF, Wagner MK, Nielsen KM, et al. Do patients with ICD who report anxiety symptoms on hospital anxiety and depression scale suffer from anxiety? J Psychosom Res. 2019;121:100\u20134.","journal-title":"J Psychosom Res"},{"key":"2724_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.106024","volume":"175","author":"L Zhang","year":"2022","unstructured":"Zhang L, Bao Y, Tao S, Zhao Y, Liu M. The association between cardiovascular drugs and depression\/anxiety in patients with cardiovascular disease: a meta-analysis. Pharmacol Res. 2022;175: 106024.","journal-title":"Pharmacol Res"},{"issue":"1","key":"2724_CR10","doi-asserted-by":"publisher","first-page":"29","DOI":"10.31887\/DCNS.2007.9.1\/jchuffman","volume":"9","author":"JC Huffman","year":"2007","unstructured":"Huffman JC, Stern TA. Neuropsychiatric consequences of cardiovascular medications. Dialog Clin Neurosci. 2007;9(1):29\u201345. https:\/\/doi.org\/10.31887\/DCNS.2007.9.1\/jchuffman.","journal-title":"Dialog Clin Neurosci"},{"issue":"10","key":"2724_CR11","doi-asserted-by":"publisher","first-page":"E634","DOI":"10.1016\/S0735-1097(13)60634-8","volume":"61","author":"K Shah","year":"2013","unstructured":"Shah K, Parekh N, Clopton P, Anand I, Christenson R, Daniels L, et al. Improved survival in patients with diastolic heart failure discharged on beta-blocker and ace inhibitors. J Am Coll Cardiol. 2013;61(10):E634. https:\/\/doi.org\/10.1016\/S0735-1097(13)60634-8.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"2724_CR12","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.jacc.2007.04.060","volume":"50","author":"S Bangalore","year":"2007","unstructured":"Bangalore S, Messerli FH, Kostis JB, Pepine CJ. Cardiovascular protection using beta-blockers: a critical review of the evidence. J Am Coll Cardiol. 2007;50(7):563\u201372.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"2724_CR13","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3390\/medicina57020155","volume":"57","author":"SA Cojocariu","year":"2021","unstructured":"Cojocariu SA, Ma\u0219taleru A, Sasc\u0103u RA, St\u0103tescu C, Mitu F, Leon-Constantin MM. Neuropsychiatric consequences of lipophilic beta-blockers. Medicina. 2021;57(2):155. https:\/\/doi.org\/10.3390\/medicina57020155.","journal-title":"Medicina"},{"issue":"2","key":"2724_CR14","first-page":"240","volume":"22","author":"E Martino","year":"2001","unstructured":"Martino E, Bartalena L, Bogazzi F, Braverman LE. The effects of amiodarone on the thyroid. Endocr Rev. 2001;22(2):240\u201354.","journal-title":"Endocr Rev"},{"key":"2724_CR15","doi-asserted-by":"publisher","DOI":"10.1111\/pace.12292","author":"TS Thompson","year":"2014","unstructured":"Thompson TS, Barksdale DJ, Sears SF, Mounsey JP, Pursell I, Gehi AK. The effect of anxiety and depression on symptoms attributed to atrial fibrillation. PACE Pacing Clin Electrophysiol. 2014. https:\/\/doi.org\/10.1111\/pace.12292.","journal-title":"PACE Pacing Clin Electrophysiol"},{"issue":"6","key":"2724_CR16","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/S0735-1097(03)81758-8","volume":"41","author":"Y Young-Xu","year":"2003","unstructured":"Young-Xu Y, Chan A, Liao JK, Ravid S, Blatt CM. Long-term statin use and psychological well-being in the elderly. J Am Coll Cardiol. 2003;41(6):153. https:\/\/doi.org\/10.1016\/S0735-1097(03)81758-8.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2724_CR17","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1093\/europace\/eur295","volume":"14","author":"MT Hoogwegt","year":"2012","unstructured":"Hoogwegt MT, Kupper N, Theuns DAMJ, Jordaens L, Pedersen SS. Beta-blocker therapy is not associated with symptoms of depression and anxiety in patients receiving an implantable cardioverter-defibrillator. Europace. 2012;14(1):74\u201380. https:\/\/doi.org\/10.1093\/europace\/eur295.","journal-title":"Europace"},{"issue":"5","key":"2724_CR18","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-004709","volume":"4","author":"SK Berg","year":"2014","unstructured":"Berg SK, Svanholm J, Lauberg A, Borregaard B, Herning M, Mygind A, et al. Patient-reported outcomes at hospital discharge from Heart Centres, a national cross-sectional survey with a register-based follow-up: the DenHeart study protocol. BMJ Open. 2014;4(5): e004709.","journal-title":"BMJ Open"},{"issue":"7 Suppl","key":"2724_CR19","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1177\/1403494810387965","volume":"39","author":"CB Pedersen","year":"2011","unstructured":"Pedersen CB. The danish civil registration system. Scand J Public Health. 2011;39(7 Suppl):22\u20135.","journal-title":"Scand J Public Health"},{"issue":"7 Suppl","key":"2724_CR20","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1177\/1403494810394715","volume":"39","author":"VM Jensen","year":"2011","unstructured":"Jensen VM, Rasmussen AW. Danish education registers. Scand J Public Health. 2011;39(7 Suppl):91\u20134.","journal-title":"Scand J Public Health"},{"issue":"7 Suppl","key":"2724_CR21","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1177\/1403494811401482","volume":"39","author":"E Lynge","year":"2011","unstructured":"Lynge E, Sandegaard JL, Rebolj M. The danish national patient register. Scand J Public Health. 2011;39(7 Suppl):30\u20133.","journal-title":"Scand J Public Health"},{"issue":"4","key":"2724_CR22","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1016\/S0735-1097(01)01109-3","volume":"37","author":"JV Tu","year":"2001","unstructured":"Tu JV, Austin PC, Walld R, Roos L, Agras J, McDonald KM. Development and validation of the ontario acute myocardial infarction mortality prediction rules. J Am Coll Cardiol. 2001;37(4):992\u20137.","journal-title":"J Am Coll Cardiol"},{"issue":"7 Suppl","key":"2724_CR23","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1177\/1403494810394717","volume":"39","author":"HW Kildemoes","year":"2011","unstructured":"Kildemoes HW, Sorensen HT, Hallas J. The danish national prescription registry. Scand J Public Health. 2011;39(7 Suppl):38\u201341.","journal-title":"Scand J Public Health"},{"key":"2724_CR24","unstructured":"The Danish Medicines Agency [Internet]. 2019 [cited 2020 Sep 24]. Available from: https:\/\/laegemiddelstyrelsen.dk\/en\/sideeffects\/side-effects-of-medicines\/."},{"key":"2724_CR25","unstructured":"The Danish Medicines Agency. Produc summaries [Internet]. [cited 2020 Nov 25]. Available from: http:\/\/www.produktresume.dk\/AppBuilder\/search."},{"key":"2724_CR26","unstructured":"E. Commision, European Directorate-General E and I. A guideline on summary of product charateristics (SmPC) [Internet]. 2009. Available from: https:\/\/ec.europa.eu\/health\/sites\/health\/files\/files\/eudralex\/vol-2\/c\/smpc_guideline_rev2_en.pdf."},{"key":"2724_CR27","unstructured":"E. Commision, European Directorate-General E and I. A guideline on summary of product charateristics (SmPC). 2009."},{"key":"2724_CR28","unstructured":"The Danish Medicines Agency. Produc summaries."},{"key":"2724_CR29","unstructured":"Danish Cardiological Society. No Title [Internet]. [cited 2020 Oct 12]. Available from: https:\/\/nbv.cardio.dk\/."},{"key":"2724_CR30","unstructured":"Marinakis C. Drug side effects [Internet]. [cited 2020 Oct 10]. Available from: https:\/\/pro.medicin.dk\/Specielleemner\/Emner\/500."},{"issue":"1","key":"2724_CR31","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12955-019-1264-0","volume":"18","author":"AV Christensen","year":"2020","unstructured":"Christensen AV, Dixon JK, Juel K, Ekholm O, Rasmussen TB, Borregaard B, et al. Psychometric properties of the Danish hospital anxiety and depression scale in patients with cardiac disease: results from the DenHeart survey. Health Qual Life Outcomes. 2020;18(1):9.","journal-title":"Health Qual Life Outcomes"},{"key":"2724_CR32","first-page":"533","volume-title":"Cardiac Nursing: a companion to Braunwald\u2019s heart disease","author":"JM Delong","year":"2008","unstructured":"Delong JM. Impact of anxiety on cardiac disease. In: Moser KD, Riegel B, editors. Cardiac Nursing: a companion to Braunwald\u2019s heart disease. Missouri: Elsevier Saunders; 2008. p. 533\u201342."},{"key":"2724_CR33","unstructured":"The Danish Medicines Agency. Information on product summaries [Internet]. [cited 2020 Nov 24]. Available from: https:\/\/laegemiddelstyrelsen.dk\/da\/bivirkninger\/find-medicin\/produktresumeer\/."},{"issue":"11","key":"2724_CR34","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/S2215-0366(20)30311-4","volume":"7","author":"Y Molero","year":"2020","unstructured":"Molero Y, Cipriani A, Larsson H, Lichtenstein P, D\u2019Onofrio BM, Fazel S. Associations between statin use and suicidality, depression, anxiety, and seizures: a Swedish total-population cohort study. Lancet Psychiatry. 2020;7(11):982\u201390.","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"2724_CR35","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2015-000276","volume":"3","author":"Y Matsuo","year":"2016","unstructured":"Matsuo Y, Kasama S, Toyama T, Funada R, Takama N, Koitabashi N, et al. Comparative effects of long-acting and short-acting loop diuretics on cardiac sympathetic nerve activity in patients with chronic heart failure. Open Hear. 2016;3(1): e000276.","journal-title":"Open Hear"},{"key":"2724_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.608083","author":"M Leutner","year":"2021","unstructured":"Leutner M, Matzhold C, Kautzky A, Kaleta M, Thurner S, Klimek P, Kautzky-Willer A. Major depressive disorder (MDD) and antidepressant medication are overrepresented in high-dose statin treatment. Front Med. 2021. https:\/\/doi.org\/10.3389\/fmed.2021.608083.","journal-title":"Front Med"},{"issue":"1","key":"2724_CR37","doi-asserted-by":"publisher","first-page":"31","DOI":"10.31887\/DCNS.2018.20.1\/mdehert","volume":"20","author":"M De Hert","year":"2018","unstructured":"De Hert M, Detraux J, Vancampfort D. The intriguing relationship between coronary heart disease and mental disorders. Dialogues Clin Neurosci. 2018;20(1):31\u201340.","journal-title":"Dialogues Clin Neurosci"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-022-02724-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-022-02724-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-022-02724-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,20]],"date-time":"2022-06-20T15:02:55Z","timestamp":1655737375000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-022-02724-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,20]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2724"],"URL":"https:\/\/doi.org\/10.1186\/s12872-022-02724-4","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,20]]},"assertion":[{"value":"6 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The DenHeart study follows the principles outlined in the Declaration of Helsinki. DenHeart was approved by the boards of the heart centres and the Danish Data Protection Agency (2007\u201358-0015\/30\u20130937). The study was registered at ClinicalTrials.gov (NCT01926145), and patients signed an informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate."}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication."}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"280"}}